simvastatin has been researched along with Hyperlipoproteinemias in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckel, RH; Grunwald, GK; Hernandez, TL; Marcovina, SM; Plenge, JK; Poirier, P; Weil, KM | 1 |
| Kipnes, MS; Lewin, AJ; Maccubbin, DL; Meneghini, LF; Mitchel, YB; Perevozskaya, IT; Plotkin, DJ; Shah, S; Tobert, JA | 1 |
| Balogh, Z; Harangi, M; Illyés, L; Kovács, P; Paragh, G; Seres, I; Törocsik, D | 1 |
| Manchanda, Y; Sharma, VK | 1 |
| Hayashi, M; Ichihara, A; Kaneshiro, Y; Koura, Y; Saruta, T; Tada, Y | 1 |
| Gordon, BR; Levine, DM; Parker, TS; Rosenson, RS; Tangney, CC | 1 |
| Capurso, A; Capurso, C; Capurso, SA; Colacicco, AM; D'Introno, A; Fontana, C; Gadaleta, AM; Koverech, A; Panza, F; Solfrizzi, V; Torres, F | 1 |
| Bláha, V; Ceska, R; Kvasnicka, T; Pit'ha, J; Soska, V | 1 |
| Budzyński, J; Fabisiak, J; Pułkowski, G; Suppan, K; Swiatkowski, M | 1 |
| Johansson, J; Lithell, H; Ohrvall, M; Vessby, B | 1 |
| Hosomi, N; Izumi, Y; Kitadai, M; Satoh, K; Takahashi, T; Tsuda, Y | 1 |
| Ikegami, T; Kano, M; Matsuzaki, Y; Miyamoto, J; Miyazaki, H; Osuga, T; Shoda, J; Tanaka, N | 1 |
| Barter, P; Clifton, P; Colquhoun, D; Hamilton-Craig, I; Nestel, P; Sikaris, K; Simons, L; Sullivan, D | 1 |
| Kukharchuk, VV; Semenova, OA; Susekov, AV; Titov, VN; Tvorogova, MG | 1 |
| Bairey-Merz, CN; Forrester, JS; Kaul, S | 1 |
| Eterović, D; Lusić, I; Pintaric, I; Reiner, Z; Tocilj, J | 1 |
| Spinar, J; Spinarová, L; Vítovec, J | 1 |
| Demant, T | 1 |
| Geiss, HC; Parhofer, KG; Schwandt, P | 1 |
| Eichinger, M; Feussner, G; Ziegler, R | 1 |
| Hockwin, O; Schmidt, J; Schmitt, C | 1 |
| Ansuini, R; Barone, A; Francolini, G; Frausini, G; Pupita, F | 1 |
1 review(s) available for simvastatin and Hyperlipoproteinemias
| Article | Year |
|---|---|
The aggressive low density lipoprotein lowering controversy.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hyperlipoproteinemias; Indoles; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin | 2000 |
12 trial(s) available for simvastatin and Hyperlipoproteinemias
| Article | Year |
|---|---|
Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction.
Topics: Adult; Aged; C-Reactive Protein; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Kinetics; Male; Middle Aged; Simvastatin | 2002 |
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Male; Middle Aged; Pioglitazone; Rosiglitazone; Simvastatin; Thiazolidinediones | 2004 |
Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
Topics: Adult; Aged; Aryldialkylphosphatase; Atorvastatin; Cross-Over Studies; Female; Heptanoic Acids; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipid Metabolism; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Simvastatin | 2004 |
Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Topics: Anticholesteremic Agents; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Cholesterol; Elasticity; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypertension; Indoles; Male; Middle Aged; Pravastatin; Prospective Studies; Pulsatile Flow; Simvastatin; Single-Blind Method | 2005 |
Elevated soluble tumor necrosis factor receptor levels in non-obese adults with the atherogenic dyslipoproteinemia.
Topics: Arteriosclerosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Male; Middle Aged; Pravastatin; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Simvastatin; Tumor Necrosis Factor Decoy Receptors | 2004 |
Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Topics: Aged; Apolipoproteins B; Carnitine; Cholesterol; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Italy; Lipoprotein(a); Male; Middle Aged; Simvastatin; Triglycerides | 2006 |
[Simvor in the treatment of hyperlipoproteinaemia].
Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Simvastatin | 2002 |
[The effect of hypolipemic therapy with diet and simvastatin on the course of angina pectoris and the results of exercise stress test in patients with coronary artery disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Disease; Exercise Test; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Simvastatin | 2005 |
A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia.
Topics: Aged; Body Weight; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Gemfibrozil; Glucose Tolerance Test; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Insulin; Lipoprotein Lipase; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Lovastatin; Male; Middle Aged; Simvastatin | 1995 |
Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.
Topics: Acyl Coenzyme A; Blood Viscosity; Cholesterol; Enzyme Inhibitors; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipoproteinemias; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin; Triglycerides | 1996 |
A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
Topics: Anticholesteremic Agents; Apolipoproteins E; Cholesterol; Cross-Over Studies; Dietary Fats; Gemfibrozil; Genotype; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemias; Hypolipidemic Agents; Insulin; Lipids; Lipoprotein(a); Lipoproteins; Lovastatin; Predictive Value of Tests; Simvastatin; Triglycerides | 1997 |
The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
Topics: Adult; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Dietary Fats; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, VLDL; Lovastatin; Male; Simvastatin; Triglycerides | 1992 |
9 other study(ies) available for simvastatin and Hyperlipoproteinemias
| Article | Year |
|---|---|
Intertriginous xanthomas: a marker of homozygous type IIa hyperlipoproteinemia.
Topics: Buttocks; Child; Cholesterol; Cholesterol, LDL; Diagnosis, Differential; Diet, Fat-Restricted; Female; Hand; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Simvastatin; Skin Diseases; Xanthomatosis | 2004 |
Simultaneous determination of plasma mevalonate and 7alpha-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemias; Intestinal Absorption; Liver; Lovastatin; Male; Mevalonic Acid; Middle Aged; RNA, Messenger; Simvastatin | 1997 |
[Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].
Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Cholesterol; Cholesterol Esters; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Indoles; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Simvastatin; Time Factors | 1998 |
Effect of simvastatin on micropulmonary red cell mass in patients with hyperlipoproteinemia.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Erythrocyte Membrane; Erythrocyte Volume; Hematocrit; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Male; Middle Aged; Pulmonary Circulation; Reproducibility of Results; Respiratory Function Tests; Simvastatin | 2001 |
[Lipids and chronic heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Heart Failure; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Prognosis; Simvastatin | 2000 |
[Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
Topics: Anticholesteremic Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromans; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Risk Factors; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
Topics: Adolescent; Adult; Diabetes Mellitus, Type 2; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Simvastatin | 2002 |
[The HMG-CoA reductase inhibitors simvastatin and pravastatin. No indication for side effects in use on humans].
Topics: Adult; Cataract; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Lovastatin; Middle Aged; Pravastatin; Refraction, Ocular; Risk Factors; Simvastatin; Visual Acuity | 1991 |
[The treatment of refractory hyperlipoproteinemias].
Topics: Anticholesteremic Agents; Cholesterol; DEAE-Dextran; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemias; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides | 1990 |